Literature DB >> 23784781

Perspectives on anti-CD47 antibody treatment for experimental cancer.

Emil R Unanue1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23784781      PMCID: PMC3704033          DOI: 10.1073/pnas.1308463110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  19 in total

1.  Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells.

Authors:  D Kim; J Wang; S B Willingham; R Martin; G Wernig; I L Weissman
Journal:  Leukemia       Date:  2012-05-30       Impact factor: 11.528

Review 2.  The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications.

Authors:  Mark P Chao; Irving L Weissman; Ravindra Majeti
Journal:  Curr Opin Immunol       Date:  2012-02-04       Impact factor: 7.486

3.  Role of CD47 as a marker of self on red blood cells.

Authors:  P A Oldenborg; A Zheleznyak; Y F Fang; C F Lagenaur; H D Gresham; F P Lindberg
Journal:  Science       Date:  2000-06-16       Impact factor: 47.728

Review 4.  The regulatory role of macrophages in antigenic stimulation. Part Two: symbiotic relationship between lymphocytes and macrophages.

Authors:  E R Unanue
Journal:  Adv Immunol       Date:  1981       Impact factor: 3.543

5.  Calreticulin exposure dictates the immunogenicity of cancer cell death.

Authors:  Michel Obeid; Antoine Tesniere; François Ghiringhelli; Gian Maria Fimia; Lionel Apetoh; Jean-Luc Perfettini; Maria Castedo; Grégoire Mignot; Theoharis Panaretakis; Noelia Casares; Didier Métivier; Nathanael Larochette; Peter van Endert; Fabiola Ciccosanti; Mauro Piacentini; Laurence Zitvogel; Guido Kroemer
Journal:  Nat Med       Date:  2006-12-24       Impact factor: 53.440

6.  The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.

Authors:  Stephen B Willingham; Jens-Peter Volkmer; Andrew J Gentles; Debashis Sahoo; Piero Dalerba; Siddhartha S Mitra; Jian Wang; Humberto Contreras-Trujillo; Robin Martin; Justin D Cohen; Patricia Lovelace; Ferenc A Scheeren; Mark P Chao; Kipp Weiskopf; Chad Tang; Anne Kathrin Volkmer; Tejaswitha J Naik; Theresa A Storm; Adriane R Mosley; Badreddin Edris; Seraina M Schmid; Chris K Sun; Mei-Sze Chua; Oihana Murillo; Pradeep Rajendran; Adriel C Cha; Robert K Chin; Dongkyoon Kim; Maddalena Adorno; Tal Raveh; Diane Tseng; Siddhartha Jaiswal; Per Øyvind Enger; Gary K Steinberg; Gordon Li; Samuel K So; Ravindra Majeti; Griffith R Harsh; Matt van de Rijn; Nelson N H Teng; John B Sunwoo; Ash A Alizadeh; Michael F Clarke; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

7.  Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte.

Authors:  Shyra J Gardai; Kathleen A McPhillips; S Courtney Frasch; William J Janssen; Anna Starefeldt; Joanne E Murphy-Ullrich; Donna L Bratton; Per-Arne Oldenborg; Marek Michalak; Peter M Henson
Journal:  Cell       Date:  2005-10-21       Impact factor: 41.582

8.  CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

Authors:  Ravindra Majeti; Mark P Chao; Ash A Alizadeh; Wendy W Pang; Siddhartha Jaiswal; Kenneth D Gibbs; Nico van Rooijen; Irving L Weissman
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

9.  Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes.

Authors:  Alice O Kamphorst; Pierre Guermonprez; Diana Dudziak; Michel C Nussenzweig
Journal:  J Immunol       Date:  2010-08-20       Impact factor: 5.422

10.  CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease.

Authors:  Per-Arne Oldenborg
Journal:  ISRN Hematol       Date:  2013-01-21
View more
  6 in total

Review 1.  CD47 signaling pathways controlling cellular differentiation and responses to stress.

Authors:  David R Soto-Pantoja; Sukhbir Kaur; David D Roberts
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-02-24       Impact factor: 8.250

2.  Surface Glycoproteins of Exosomes Shed by Myeloid-Derived Suppressor Cells Contribute to Function.

Authors:  Sitara Chauhan; Steven Danielson; Virginia Clements; Nathan Edwards; Suzanne Ostrand-Rosenberg; Catherine Fenselau
Journal:  J Proteome Res       Date:  2016-10-20       Impact factor: 4.466

Review 3.  Recent Advancement and Technical Challenges in Developing Small Extracellular Vesicles for Cancer Drug Delivery.

Authors:  Tianjiao Geng; Patrick Pan; Euphemia Leung; Qi Chen; Larry Chamley; Zimei Wu
Journal:  Pharm Res       Date:  2021-02-18       Impact factor: 4.200

Review 4.  Molecular cargo in myeloid-derived suppressor cells and their exosomes.

Authors:  Catherine Fenselau; Suzanne Ostrand-Rosenberg
Journal:  Cell Immunol       Date:  2020-12-07       Impact factor: 4.868

Review 5.  Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity.

Authors:  Rajkumar Noubade; Sonia Majri-Morrison; Kristin V Tarbell
Journal:  Front Immunol       Date:  2019-05-09       Impact factor: 7.561

Review 6.  Targeting phosphatidylserine for Cancer therapy: prospects and challenges.

Authors:  Wenguang Chang; Hongge Fa; Dandan Xiao; Jianxun Wang
Journal:  Theranostics       Date:  2020-07-23       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.